{
    "id": 27229,
    "fullName": "BRCA1 E29Sfs*2",
    "impact": "frameshift",
    "proteinEffect": "loss of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "BRCA1 E29Sfs*2 indicates a shift in the reading frame starting at amino acid 29 and terminating 2 residues downstream causing a premature truncation of the 1863 aa Brca1 protein (UniProt.org). Due to the loss of most known functional domains (UniProt.org), E29Sfs*2 is predicted to result in a loss of Brca1 protein function; however, the corresponding cDNA change has been demonstrated to act as a reversion mutation in the context of a specific inactivating BRCA1 mutation, leading to restoration of the BRCA1 open reading frame and wild-type protein function, as demonstrated by induction of Brca1 foci formation following ionizing irradiation in vitro and association with acquired resistance to platinum-based chemotherapy (PMID: 28765325).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 10297,
                    "pubMedId": 28765325,
                    "title": "Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28765325"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 672,
        "geneSymbol": "BRCA1",
        "terms": [
            "BRCA1",
            "BRCAI",
            "BRCC1",
            "BROVCA1",
            "FANCS",
            "IRIS",
            "PNCA4",
            "PPP1R53",
            "PSCP",
            "RNF53"
        ]
    },
    "variant": "E29Sfs*2",
    "createDate": "11/13/2017",
    "updateDate": "09/11/2018",
    "referenceTranscriptCoordinates": {
        "id": 155633,
        "transcript": "NM_007294",
        "gDna": "chr17:g.43115776delC",
        "cDna": "c.85delG",
        "protein": "p.E29Sfs*2",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 13099,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, an ovarian cancer patient harboring BRCA1 E23Vfs*17 progressed while being treated with platinum-based chemotherapy, and via cell-free DNA testing was found to have acquired somatic reversion mutations, BRCA1 E29Sfs*2 and BRCA1 K38Sfs*12, which restored the open reading frame, resulting in wild-type BRCA1 protein function (PMID: 28765325).",
            "molecularProfile": {
                "id": 29007,
                "profileName": "BRCA1 E23Vfs*17 BRCA1 E29Sfs*2 BRCA1 K38Sfs*12"
            },
            "therapy": {
                "id": 1092,
                "therapyName": "Carboplatin",
                "synonyms": null
            },
            "indication": {
                "id": 2394,
                "name": "ovarian cancer",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 10297,
                    "pubMedId": 28765325,
                    "title": "Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28765325"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 28649,
            "profileName": "BRCA1 E29Sfs*2",
            "profileTreatmentApproaches": [
                {
                    "id": 17890,
                    "name": "PARP-1 Inhibitor",
                    "profileName": "BRCA1 E29Sfs*2"
                },
                {
                    "id": 17891,
                    "name": "PARP Inhibitor (Pan)",
                    "profileName": "BRCA1 E29Sfs*2"
                }
            ]
        },
        {
            "id": 29007,
            "profileName": "BRCA1 E23Vfs*17 BRCA1 E29Sfs*2 BRCA1 K38Sfs*12",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 155634,
            "transcript": "NM_007300",
            "gDna": "chr17:g.43115776delC",
            "cDna": "c.85delG",
            "protein": "p.E29Sfs*2",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 155636,
            "transcript": "NM_007298",
            "gDna": "chr17:g.43115776delC",
            "cDna": "c.85delG",
            "protein": "p.E29Sfs*2",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 155635,
            "transcript": "NM_007299",
            "gDna": "chr17:g.43115776delC",
            "cDna": "c.85delG",
            "protein": "p.E29Sfs*2",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 155633,
            "transcript": "NM_007294",
            "gDna": "chr17:g.43115776delC",
            "cDna": "c.85delG",
            "protein": "p.E29Sfs*2",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}